Novo Nordisk A/S
$41.43
-3.56%(-1.53)
▼Why is $NVO Down Today?
$NVO is down 3.56% today. Check the latest news below for potential catalysts.
For educational purposes only
30-Day Price History
AlphaFeed Signal History
Full tracker →US-listed shares of Novo Nordisk jumped 3% after the Danish drugmaker announced a partnership with OpenAI to accelerate AI-driven drug discovery. The deal expands pharma's AI buildout and pairs a GLP-1 giant with the leading AI lab.
Risk: Partnership may lack near-term revenue impact; market could fade hype quickly.
Latest News
Novo Nordisk: The Biggest Healthcare Bargain
SeekingAlpha
Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs
Benzinga
Wall Street Breakfast Podcast: Pfizer Chases Monthly Edge
SeekingAlpha
Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'
Benzinga
Novo Nordisk A/S (NOVO:CA) Discusses Obesity and Diabetes Portfolio Progress and Pill Launch Milestones at R&D Event Transcript
SeekingAlpha
Key Stats
Track this ticker
AlphaFeed HQ content is for educational purposes only. This is not financial advice. Do not buy, sell, or hold any security based on this content. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. AlphaFeed HQ is not a registered investment advisor. For educational purposes only.